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PHIP was isolated as an insulin receptor substrate 1 (IRS-1) interacting protein. To date, the physi-
ological roles of PHIP remain unknown. Here we show that mice lacking PHIP1, the full-length iso-
form of PHIP, are born at normal size but suffer a 40% growth deﬁcit by weaning. PHIP1 mutant
mice develop hypoglycemia and have an average lifespan of 4–5 weeks. PHIP1-deﬁcient mouse
embryonic ﬁbroblasts (MEFs) grow markedly slower than wild-type MEFs, but exhibit normal AKT
phosphorylation and an increased cell proliferation in response to IGF-1 treatment. Together these
results suggest that PHIP1 regulates postnatal growth in an IGF-1/AKT pathway-independent
manner.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Insulin and insulin-like growth factor 1 (IGF-1) are key regula-
tors of cell metabolism, proliferation, differentiation and survival
[1]. Their potent metabolic and mitogenic effects are initiated by
receptor-mediated tyrosine phosphorylation of a family of four
insulin receptor substrates (IRS-1 to IRS-4) [2–5]. These proteins,
which differ in tissue distribution, subcellular localization and
developmental expression, subsequently act as docking sites for
the recruitment and activation of a complex network of intracellu-
lar Src homology 2-containing signaling molecules [6,7]. Available
data from knockout mouse models indicate that IRS-1 and IRS-2, as
the principal substrates for insulin and insulin-like growth factor
(IGF-1) receptor tyrosine kinases, play a central role in eliciting
the pleitropic effects of insulin and IGF-1 [8].
The amino terminus of the IRS proteins contains a highly
conserved pleckstrin homology (PH) domain that is critical for
insulin/IGF-1 receptor and IRS interactions [9,10]. PHIP (PH-inter-
acting protein) was originally isolated as a 100-kDa (902 amino
acids) protein through yeast two-hybrid screening. Biochemicalchemical Societies. Published by E
e, South China Agricultural
icultural University, Sichuan,studies revealed that PHIP is a cytoplasmic protein that selectively
interacts with the PH domain of IRS-1 [11]. Subsequent functional
analysis in human ﬁbroblast cells showed that PHIP is required for
insulin receptor-mediated mitogenic and metabolic signal trans-
duction [12]. More recently, a novel 206-kDa (1821 a.a.) isoform
of PHIP (PHIP1) containing a WD-40 domain and two bromodo-
mains has been isolated from mouse pancreatic islets [13]. In con-
trast to PHIP, PHIP1 was shown to be exclusively localized in the
nuclear compartment of pancreatic b cells. Based on evidence from
overexpression and RNA interference studies in pancreatic b-cell
lines, it has been suggested that PHIP1 is involved in control of
b-cell proliferation and survival in an IGF-1-dependent and inde-
pendent manner.
The physiological roles of the PHIP proteins remain unknown.
By microinjection of a gene-trapped mouse embryonic stem (ES)
cell clone into C57BL/6J blastocyts, we have recently generated
mice carrying a gene-trapped Phip allele. We report here that mice
homozygous for the gene-trap mutation in Phip (Phip/) suffer
from a severe postnatal growth deﬁcit. The average lifespan of via-
ble mutant mice is 4–5 weeks. These mice are slightly glucose
intolerant and develop hypoglycemia. Mouse embryonic ﬁbro-
blasts (MEFs) from Phip/ mice grow signiﬁcantly slower than
wild-type MEFs, but remain responsive to IGF-1 mitogenic signals.
Our data suggest that PHIP1 controls postnatal body growth by
functioning independently of the IGF-1/AKT pathway.lsevier B.V. All rights reserved.
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2.1. Mice
Phip gene-trapmicewere generated bymicro-injection ofmouse
embryonic stem cell line RRJ571 (Baygenomics) into C57BL/6J blas-
tocysts. The resulting chimeric male founders were crossed to
C57BL/6J females to generate F1 heterozygous (Phip+/) mice.
Phip+/ mice were then intercrossed to generate F2 homozygous
Phip/ mice or embryos. Genotyping of all animals or embryos
was done by PCR using primers F4, R1 and R5 (Supplementary
Table 1). All animal experimentswereperformed in accordancewith
the Cornell Animal Care and Use Guidelines.2.2. Physiological studies
Plasma insulin concentrations were measured using a Rat Insu-
lin RIA Kit (Millipore). Glucose tolerance and insulin tolerance tests
(GTT and ITT) were performed essentially as described [14]. Brieﬂy,
for glucose tolerance test, mice were fasted for 6–8 h and then in-
jected intraperitoneally (IP) with 2 g per kg body weight of D-glu-
cose. Glucose measurements were taken at 0, 5, 15, 30, 60 and
120 min post-injection using an Ascensia Elite XL glucometer
(Bayer). Blood was collected from the tail vein at each time point
during the glucose tolerance test and plasma insulin levels were
determined by ELISA (Crystal Chem). For insulin tolerance test,
mice were fasted for 6 h and then injected IP with 0.75 U per kg
body weight of regular human insulin (Eli Lilly, IN) dissolved in
phosphate-buffered saline (PBS). Glucose measurements were ta-
ken at 0, 5, 15, 30, 60 and 120 min post-injection.2.3. Morphological studies
Hindlimb skeletal muscle, liver and lung were dissected from
wild-type and mutant mice at 3 weeks of age, ﬁxed in 4% parafor-
maldehyde (PFA) in PBS at 4 C overnight and then processed for
parafﬁn embedding. 5-lm sections were mounted on glass slides
and stained with hematoxylin and eosin. All images were acquired
using an Axiovert 40 microscope (Zeiss) equipped with an Axio-
Cam camera. Hepatocyte and skeletal muscle ﬁber sizes were mea-
sured using the AxioVision software (Version 4.1).2.4. RNA isolation and quantitative RT-PCR
RNA was isolated using the TRIZOL RNA Isolation Kit (Invitro-
gen). For quantitative RT-PCR analysis, total RNA was treated with
DNase I for 10 min and puriﬁed using the RNAqueous-Micro Kit
(Ambion). cDNA was synthesized using SuperScript III Reverse
Transcriptase (Invitrogen). Quantitative PCR (qPCR) was performed
using Power SYBR Green PCR Master Mix on an ABI Prism 7000 Se-
quence Detection System (Applied Biosystems). All qPCR primers
(Supplementary Table 1) were designed using the PrimerSelect
program of Lasergene 7.1 Sequence Analysis Software (DNAStar).
Quantiﬁcation of expression and normalization were done essen-
tially as described [15].2.5. Cell proliferation assays
Wild-type and Phip/ MEF cells were isolated and cultured as
described [16]. For IGF-1 treatment, MEF cells were plated at a
density of 2.4  104 cells per 60-mm dish in complete medium.
After 12 h of culture, the cells were serum-starved overnight and
then 100 ng/ml of human IGF-1 (National Hormone and Peptide
Program, UCLA) was added into the serum-free medium. Mocktreatment was carried out by adding an equal volume of PBS into
the culture medium. Cells were counted daily for 6 consecutive
days.
[3H]Thymidine incorporationassaywasperformedessentially as
described [17]. Brieﬂy, wild-type and Phip/MEF cells were plated
in triplicates in 48-well plates at a density of 7.5  103 cell/well and
grown in complete medium overnight. MEFs were serum-starved
for 24 h and subsequently cultured in basal medium with 25, 50,
100 and 200 ng/ml of recombinant human IGF-1 for 18 h in the
presence of [Methyl-3H] thymidine at a ﬁnal concentration of
1 lCi/well (MP Biochemicals, CA). MEFs were then washed 3 times
with cold PBS. DNA was precipitated with 500 ll of cold 10%
trichloroacetic acid and solubilized by the addition of 100 ll of
0.3 N NaOH. The amount of [3H] thymidine incorporated into DNA
was measured by liquid scintillation counting and normalized to
the amount of total cellular protein.
2.6. AKT phosphorylation and Western blot analysis
Phip+/+ and Phip/ MEFs were seeded at 5  106 cells per 100-
cm dish and cultured for 16 h in complete medium. The MEFs were
serum-starved overnight and treated with 100 ng/ml IGF-1 for 0, 5,
10 and 30 min. Total proteins were extracted using cell extraction
buffer containing 0.05 M Tris–HCl at pH 8.0, 0.15 M NaCl, 5.0 mM
EDTA, 1% NP-40 and a protease inhibitor cocktail (MBL) at 4 C.
After centrifugation, soluble protein in the extract was quantiﬁed
using bicinchoninic acid (BCA) assay (Pierce, Rockford, IL). Proteins
were fractionated by SDS-10% PAGE, transferred to nitrocellulose
membranes and probed with primary antibodies recognizing total
AKT and AKT phosphorylated on serine 473 (Cell Signaling). Pri-
mary antibody binding was detected by using horseradish peroxi-
dase coupled to goat anti-rabbit immunoglobulin G (IgG) or
donkey anti-goat IgG (1:10,000). The antibody complex was visual-
ized by incubation with the Lumi-Light Western blotting substrate
(Roche-Mannhein, Mannhein, Germany).
2.7. Statistical analysis
Differences between compared groups were evaluated by per-
forming two-tailed Student’s t-test and P < 0.05 is considered
signiﬁcant.3. Results
3.1. Generation and molecular characterization of Phip gene-trap
mutant (Phip/) mice
The Phip gene-trap mice were generated by microinjection of a
mouse embryonic stem (ES) cell clone, RRJ571, into C57/B6 blasto-
cysts. This clone contains an exon-trap cassette in intron 4 of the
Phip gene. To identify the insertion site for the gene-trap, we car-
ried out PCR-based chromosome walking using a series of forward
and reverse primers speciﬁc to intron 4. The trap is located approx-
imately 1516-bp downstream of exon 4 (Fig. 1A).
The gene-trap cassette in Phip contains a strong splicing accep-
tor site and a b-galactosidase-neomycin (bgeo) fusion gene. This
cassette is expected to block splicing between exon 4 and 5, result-
ing in a fusion protein containing the 63 amino acids of the N-ter-
minus of PHIP1 and (bgeo (Fig. 1B). To assess this, we performed
semi- and quantitative RT-PCR analyses of liver RNAs from wild-
type (Phip+/+), heterozygous (Phip+/) and homozygous (Phip/)
mice using Phip and bgeo speciﬁc primers (Fig. 1C, arrows). As ex-
pected, a wild-type amplicon was detected in Phip+/+and Phip+/
mice, but not in Phip/ mice; in contrast, a Phip-bgeo fusion
amplicon was detected in Phip+/ and Phip/ mice, but not in
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Fig. 1. Generation and characterization of Phip gene-trap mice. (A) Schematic representation of wild-type (Phip+) and mutant (Phip) Phip alleles. Filled boxes represent
exons; the open box in Phip denotes the gene-trap cassette. Dashed lines indicate RNA splicing events. (B) Schematic representation of wild-type and mutant PHIP peptides
generated from Phip+ and Phip, respectively. The number of amino acids for each peptide is indicated. The mutant peptide is a fusion protein containing the N-terminal 63
amino acids of PHIP1 and full-length bgeo. (C and E) RT-PCR analysis of liver RNAs from Phip+/+, Phip+/ and Phip/ mice. PCR primers (arrows) and their locations in
corresponding cDNAs are indicated on the top. For each genotype, PCR products from the indicated two primer pairs were pooled and resolved using a 2% agarose gel. In (C)
upper and lower bands represent products ampliﬁed by F1/R2 and F1/R1, respectively. In E, upper and lower bands represent products ampliﬁed by F2/R3 and F3/R4,
respectively. (D and F) Quantiﬁcation of transcripts in C and E by quantitative RT-PCR. Genotypes of the RNA are indicated as +/+, +/ and /, respectively. qPCR primers are
shown on top of the bar graph. N = 3 mice per genotype, *, P < 0.05 Phip/ versus Phip+/+ mice. (G) Distribution of Phip+/+, Phip+/ and Phip/ mice. Numbers in parentheses
indicate expected distribution. (H) Survival rate of Phip/ mice during postnatal period. A total of 37 newborn Phip/ pups were monitored in a 3-week window.
S. Li et al. / FEBS Letters 584 (2010) 4121–4127 4123Phip+/+mice (Fig. 1C and D). Available information in the NCBI Gen-
bank database predicts multiple alternatively spliced transcripts
for the mouse Phip gene. To assess this, we carried out additionalRT-PCR analysis using isoform-speciﬁc primers (Fig. 1E). Indeed,
at least one smaller transcript, encoding the 902 a.a. isoform of
PHIP, was detected and found to be up-regulated in Phip/ mice
4124 S. Li et al. / FEBS Letters 584 (2010) 4121–4127(Fig. 1E and F). Together, these results indicate that Phip/ mice
are void of the full-length isoform of PHIP (PHIP1), but retain the
902-a.a. and possibly other isoforms of PHIP peptides. Thus, the
Phip/ mice reported here are not PHIP- null mutants.
Heterozygous mice (Phip+/) appeared morphologically normal
and were fertile. Of the 272 weaned offspring from intercrossing
Phip+/ mice, only 32 Phip/ mice (11.7%) were found (Fig. 1G).
No Phip/ mice was found 6 weeks after birth. To determine
whether homozygous mutants were under-represented at birth,
we determined the distribution ratio of wild-type, heterozygous
and homozygous animals at birth. Of 108 new born mice, only
19 Phip/mice (17.6%) were found (Fig. 1G), suggesting that some
Phip/ embryos died during development. Phip/ mice had an
average lifespan of about 4 weeks, with the longest living mouse
so far at 5 weeks of age (Fig. 1H). Overall, these results indicate that
PHIP1 plays a non-essential role during embryogenesis, but is crit-
ically required for postnatal growth and survival of mice.A B
C D
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I J
Fig. 2. Inactivation of PHIP1 impairs postnatal whole body growth. (A) Representative im
weight gain proﬁles of Phip+/+, Phip+/ and Phip/ mice. N = 10 per genotype, *P < 0.05,
muscle cross sections from Phip+/+ (C) and Phip/ (D) mice. (F and G) H&E staining of liver
from Phip+/+ (I) and Phip/ (J) mice. (E, H and K) Quantiﬁcation of sizes of myocytes (E),
**P < 0.01 Phip/ versus Phip+/+ mice. All data are expressed as mean ± standard deviati3.2. PHIP1 regulates postnatal tissue growth and functioning
All Phip/mice that survived to weaning appeared to be mark-
edly smaller than their wild-type littermate control mice (Fig. 2A).
To determine whether the growth deﬁciency of Phip/ mice was
the result of fetal or postnatal growth deﬁciency, we monitored
the growth rate of Phip/ mice from birth to weaning (Fig. 2B).
New born Phip/ pups had comparable weights to their wild-type
and Phip+/ littermates. However, by 1 week of age, Phip/ mice
appeared to be smaller than their wild-type and Phip+/mice litter-
mates. During the next 2–3 weeks, the body weight difference be-
tween Phip/ and wild-type mice increased progressively. To
further assess the growth phenotype of Phip/mice, we compared
the tissue/body weight ratio for various tissues between Phip/
and wild-type mice (Table 1). No signiﬁcant difference was found
between the two genotypes in the relative weight of heart, liver,
lung, hindlimb muscle, pancreas and spleen. However, Phip/Age (days)
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Table 1
Organ/body weight ratios of Phip+/+ and Phip/ mice.
Body weight (g) Adipose
(%)
Heart
(%)
Liver
(%)
Lung
(%)
Hindlimb muscle
(%)
Pancreas
(%)
Spleen
(%)
Phip+/+ 14.8 ± 0.73 1.79 ± 0.26 0.52 ± 0.05 3.72 ± 0.39 1.94 ± 0.19 1.32 ± 0.30 1.02 ± 0.07 0.40 ± 0.05
Phip/ 8.9 ± 1.63 0.25 ± 0.14 0.51 ± 0.19 4.18 ± 0.32 2.38 ± 0.42 0.81 ± 0.19 1.34 ± 0.29 0.32 ± 0.10
Phip+/+ (n = 4) and Phip/ (n = 3) mice were sacriﬁced at three weeks of age. The major visceral organs, abdominal fat and hindlimb skeletal muscle were weighed and
averaged according genotype. The averaged organ weight was used to calculate an organ to body weight ratio. The data are expressed as mean ± standard deviation. Note that
mutant mice had a signiﬁcantly lower abdominal fat content than wild-type mice.
S. Li et al. / FEBS Letters 584 (2010) 4121–4127 4125mice had a signiﬁcantly lower adipose/body weight ratio than
wild-type mice. Next we sought to determine whether cell size
plays a role for the observed growth phenotype in Phip/ mice.
Phip/ myocytes were signiﬁcantly reduced in size as compared
to wild-type myocytes (Fig. 2C–E). Phip/ hepatocytes, although
morphologically normal, also appeared to be signiﬁcantly smaller
than wild-type hepatocytes (Fig. 2F–H). These results are in line
with the notion that a major contributor to the postnatal growth
phenotype of Phip/ mice is hypotrophy of somatic cells.
Phip/ mice appeared to have a healthy heart and had no
symptom of tumor or infectious disease development at the time
of their death. We speculated that their death may relate to the im-
proper development or failure of some internal organs. Thus, we
carried out histological analysis of the lung in Phip/ mice. The
lung epithelium in Phip/ mice was poorly developed, had se-
verely dilated airways and appeared to contain signiﬁcantly fewer
red blood cells (Fig. 2I–K). Based on this observation, it is possible
Phip/ mice die due to a progressively failing lung function. Fur-
ther studies are needed to determine whether functional abnor-
malities are present in other organs or tissues of Phip/ mice.Postnatal days
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Fig. 3. Phip/ mice progressively develop hypoglycemia. (A) Fasting blood glucose leve
blood glucose concentrations were measured at postnatal day 1, 7, 14 and 21. N = ? per
concentrations in Phip+/+ and Phip/ mice. Mice were fasted for 8 h and plasma insulin
test. Phip+/+ and Phi/ mice at 3 weeks of age were IP injected with 0.75 U per kg body
120 min post insulin injection. (D) Glucose tolerance test. 3-week old Phip+/+ and Phip/m
measurements were taken at 0, 15, 30, 60 and 120 min post glucose injection. *P < 0.053.3. PHIP1-deﬁcient mice develop hypoglycemia
PHIP1 is highly expressed in the pancreatic b cells and was
shown to be required for pancreatic b-cell proliferation [13]. In
addition, PHIP, an alternatively spliced isoform of PHIP1, was iso-
lated as an IRS-1 interacting protein and was previously showed
to be involved in insulin signal transduction [12,18]. Thus, we next
assessed whether PHIP1-deﬁcient mice were defective in glucose
metabolism. Basal blood glucose levels of Phip+/+ and Phip/ mice
were monitored from birth to 3 weeks of age. No signiﬁcant differ-
ence was observed in basal blood glucose levels among the three
genotypes at birth. However, 5 days after birth Phip/ mice
showed a lower blood glucose level than Phip+/+ mice; and they
progressively developed severe hypoglycemia during the next
two weeks (Fig. 3A). We monitored the daily activity and feeding
behavior of these mice and found that Phip/mice were physically
active and appeared to have normal feeding behavior. We also
determined the plasma insulin levels of Phip+/+ and Phip/ mice
and found that Phip/ mice had a comparable fasting serum insu-
lin level as Phip+/+ mice (Fig. 3B). These results suggest that neitherBl
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4126 S. Li et al. / FEBS Letters 584 (2010) 4121–4127under-nutrition nor hyperinsulinemia contributed to the hypogly-
cemia in Phip/ mice. Given the fact the transcript encoding PHIP
is up-regulated in Phip/ mice, we tested the hypothesis that
Phip/ mice may be more sensitive to insulin. Indeed, insulin tol-
erance tests (ITT) indicated that the same dosage of insulin had
stronger glucose-lowering effect in Phip/ mice than in wild-type
control mice (Fig. 3C). Despite the proposed role of PHIP1 in pro-
moting b-cell proliferation, Phip/ mice appeared to have ade-
quate pancreatic function, as revealed by glucose intolerance
tests (Fig. 3C). Together, these data indicate that PHIP1 deﬁciency
sensitizes mice to insulin action, but does not affect insulin pro-
duction in the pancreas.Phip+/+
Phip-/-
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signaling pathway
To investigate the molecular mechanisms underpinning the
growth deﬁciency of Phip/ mice, we isolated mouse embryonic
ﬁbroblast cells from E13.5 Phip/ embryos and characterized their
growth. Phip/ MEFs, while morphologically indistinguishable
from Phip+/+ MEFs, grew signiﬁcantly more slowly than wild-type
MEFs (Fig. 4A). This result, which is consistent with the previous
ﬁnding that PHIP1 is involved in regulating pancreatic b-cell prolif-
eration [13], suggests that hypoplasia likely contributed to the
growth deﬁciency of Phip/ mice. Since PHIP1 was shown to pro-
mote cell proliferation in both IGF-1-dependent and independent
manners [13], and the growth phenotype of Phip/mice resemble
that of IGF-1 receptor (Igf1r) knockout mice [19], we tested
whether PHIP1 functionally interacts with the IGF-1/AKT signaling
pathway. Mouse embryonic ﬁbroblast (MEF) cells from E13.5
Phip+/+ and Phip/ embryos were treated with 100 ng/ml human
IGF-1 for various times and AKT phosphorylation was assessed
by Western blot analysis. Phip/ MEFs showed normal levels of
AKT phosphorylation at the 473 serine residue upon IGF-1 treat-
ment (Fig. 4B). This result suggests that inactivation of PHIP1 does
not impair IGF-1/AKT signal transduction. We next assessed
whether Phip/ MEFs increase DNA synthesis in response to IGF-
1 treatment using [3H]-thymidine incorporation assay. Phip/
MEFs, upon treatment with various concentrations of IGF-1, exhib-
ited a dose-dependent increase of DNA synthesis in response to
IGF-1 (Fig. 4C). Taken together, these data are consistent with the
notion that PHIP1 is required for postnatal growth and functions
independently of the IGF-1/AKT pathway.0 25 50 100 200
Concentration of IGF-1 (ng/ml)
Fig. 4. PHIP1 regulates MEF cell proliferation in an IGF-1/AKT independent manner.
(A) Rate of Phip+/+ and Phip/ MEF cell proliferation. MEFs from E13.5 Phip+/+ and
Phip/ embryos were plated at a density of 2.4  104 per 60-mm plate and cultured
for a week. Cells were counted every 24 h. *P < 0.05, **P < 0.01 Phip/ versus Phip+/+
MEFs. (B) Western blot analysis of AKT phosphorylation in Phip+/+ and Phip/MEFs.
MEFs of deﬁned genotypes were plated at a density of 5.6  106 per 100-mm dish.
After serum-starving for 24 h, the MEFs were treated with IGF-1 (100 ng/ml) for 0,
5, 10 and 30 min. MEF cell lysates were prepared in RIPA lysis buffer and resolved
on 7% SDS–PAGE. Total and phosphorylated (serine 473) AKT were detected using
anti-AKT and anti-pAKT antibodies. (C) [3H] Thymidine incorporation assay of DNA
synthesis of Phip+/+ and Phip/MEFs in response to IGF-1. Phip+/+ and Phip/MEFs
were plated in triplicates in 48-well plates (7.5  103 cells/well), grown and serum-
starved as described in (B). MEFs were treated with 25, 50, 100 and 200 ng/ml of
human IGF-1 for 18 h in the presence of 1 lCi of [3H] thymidine per well. *P < 0.05,
**P < 0.01 non-treated versus treated Phip+/+ MEFs. #P < 0.05, ##P < 0.01 non-
treated versus treated Phip/ MEFs.4. Discussion
We report here that mice homozygous for a gene-trap mutation
in the Phip gene (Phip/) exhibit severe whole body growth deﬁ-
ciency during postnatal period. Mutant hepatocytes and myocytes
appear to be signiﬁcantly smaller than those of wild-type mice.
Mutant MEFs are smaller in size and grow signiﬁcantly slower than
wild-type control MEFs. Taken together, these ﬁndings suggest
that Phip is an important regulator of somatic cell growth and cell
sizes in mice. To the best of our knowledge, this represents the ﬁrst
in vivo functional study for the mammalian Phip gene.
Available sequence information in the NCBI Genbank database
indicates that the mouse Phip gene has multiple alternative spliced
transcripts. These transcripts are predicted to encode at least 4
PHIP proteins with sizes ranging from 902 to 1821 amino acids
[13]. The cDNAs encoding PHIP and PHIP1, the 902 and 1821 a.a.
variant, respectively, were previously cloned. It has been shown
that PHIP, a cytosolic protein, selectively interacts with the PH do-
main in IRS-1 and is involved in insulin and IGF-1 signaling [11,12].
In contrast, PHIP1, the 1821 a.a. isoform, was found to be exclu-
sively localized in the nucleus of mouse pancreatic b cells, anindication that PHIP1 may function as a transcription factor [13].
Indeed, overexpression of PHIP1 promotes cyclin D2 gene expres-
sion, whereas RNAi-mediated knocking-down of PHIP1 suppresses
cyclin D2 expression [13]. We show by semi- and quantitative RT-
PCR that the full-length Phip transcript, encoding PHIP1, is absent
S. Li et al. / FEBS Letters 584 (2010) 4121–4127 4127in Phip/ mice (Fig. 1C and D). However, the transcript that en-
codes the 902 a.a isoform of PHIP is detectable and, interestingly,
up-regulated in the homozygous mutants (Fig. 1E and F). These re-
sults strongly suggest that Phip is a hypermorphic allele and that
it is the inactivation of PHIP1, the 1821 a.a. isoform, that is respon-
sible for the observed postnatal growth phenotype in Phip/mice.
Phip/ mice gradually develop hypoglycemia during postnatal
period, albeit that they have a comparable serum insulin level to
their wild-type littermate control mice. The molecular mecha-
nisms underlining this glucose metabolic phenotype remains un-
clear. Given the fact that the Phip transcripts encoding the 902
a.a. isoform of PHIP is up-regulated in Phip/ mice, and that this
isoform of PHIP was previously implicated in insulin signal trans-
duction [11,12], it is possible that Phip/ mice may be more sen-
sitive to insulin due to an enhanced insulin signaling pathway.
Further biochemical studies are needed to determine the molecu-
lar defects of the insulin signaling pathway.
Phip/mice exhibit a growth deﬁciency that is similar in sever-
ity to that of IGF-1 null mice (60% of the body weight of wild-type
mice) [19,20]. Additionally, a previous study in vitro showed that
PHIP1 promotes pancreatic b cell proliferation in an IGF-1/IRS-2
dependent and independent manner [13]. Given the previous ﬁnd-
ing that PHIP1 is exclusively localized in the nucleus [13], we
tested whether PHIP1 functions as a downstream target of the
IGF-1/AKT signaling pathway. We show that PHIP1-deﬁcient MEFs
exhibit an intrinsically slower growth than wild-type MEFs
(Fig. 4A). Surprisingly, in response to exogenous IGF-1 PHIP1-deﬁ-
cient MEFs increase DNA synthesis in an IGF-1 dose-dependent
manner (Fig. 4C). Further, we show by Western blot analysis that
Phip/ MEFs have normal AKT phosphorylation following IGF-1
treatment. Together, these observations suggest that PHIP1 regu-
lates postnatal growth in an IGF-1/AKT pathway-independent
manner. Several functional pathways, namely the IGF-1/PI3/AKT,
IGF-1/RAS/MAPK and IGF-1/PDK1/p70S6K pathways, have been
implicated in the transduction of IGF-1 signals [1,21–23]. It re-
mains to be determined whether PHIP1 functions as a downstream
target of the IGF-1/RAS/MAPK and IGF-1/PDK1/p70S6k pathways.
In conclusion, we report that mice deﬁcient for the full-length
isoform of PHIP, PHIP1, are severely retarded during postnatal body
growth. PHIP1 appear to act in an IGF-1/AKT-independent manner.
The mouse genome contains two Phip-related genes: Brwd1 and
Brwd3 (Bromodomain and WD-repeat containing genes). BRWD1,
PHIP1 and BRWD3 are structurally conserved and seem to have
overlapping expression patterns [24]. Mice deﬁcient for BRWD1,
however, were largely normal except that both males and females
are infertile [24], suggesting that members of the BRWD family
may have redundant functions. Further proof of this requires the
generation of BRWD1 and PHIP1 double mutant mice.
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